here are 4 mass. biotechs making noise at the ash conference so far .
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
share your thoughts
110 Used Today
273 Used Today
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .